Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionWiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activationRegulation of immune cell function and differentiation by the NKG2D receptorNKG2D ligands as therapeutic targetsGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionCytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2ANKG2D CARs as cell therapy for cancer.Interleukin 10 decreases MICA expression on melanoma cell surface.The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2DModulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation.Ionomycin Treatment Renders NK Cells Hyporesponsive.Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAdoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.Proteasome regulation of ULBP1 transcription.Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy CellsSynergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation.B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.Combination strategies to enhance antitumor ADCC.Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications.Novel immune modulators used in hematology: impact on NK cellsMolecular mechanisms of natural killer cell activation in response to cellular stress.The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activityγδ T cells as a potential tool in colon cancer immunotherapy.Cellular senescence: from growth arrest to immunogenic conversion.Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice.Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.Matrine regulates immune functions to inhibit the proliferation of leukemic cells.The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy.Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases.Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells.The Paradoxical Role of NKG2D in Cancer Immunity
P2860
Q21131219-FC0AE69D-CF55-4EED-A8BC-0CC583B72AAEQ24322081-CC4CD5E3-7B9A-4A76-A0E5-EA09797B4207Q24635093-1B50603E-5B27-4DFB-B35E-C4539221BD0EQ27014888-7FF857AE-E0D0-4004-B183-B60AB04A1B34Q28076151-8A7EB097-F2EF-4D6C-BA82-BEEAF9B8E810Q28731856-A3B5E303-7DC0-4FA6-A826-51ADBCCE8A04Q33595873-1C6568B0-0D69-4339-997D-DFCBE5523A19Q34131549-46BD6AE8-F515-44FA-AAC1-B6121F797FBEQ34467682-EEE5AB06-A494-4596-AD91-9ECD87988B4DQ35031677-038127C5-743F-4F67-B100-AD94F1A89800Q35967256-3D59F4DA-005A-4825-9146-46382D71480EQ36309488-94A329C7-EBA1-40AC-8D40-0661882CE12AQ37071112-A9BF9932-771E-445E-AFEE-8FA75DDA9717Q37169138-A4D0D153-30AE-4318-A336-1E1EBAEEB0C4Q37357720-F2E2BE48-EFCC-4340-9508-B177D0232E53Q37559284-0DAF8EA7-BD48-4A27-8FB0-BCC4A7BDC728Q37581705-C2B8B94D-9241-4A2D-93B2-B3F9BD0CE6D8Q37923837-45056DF4-C5E7-48AD-BE3B-E15C68C73457Q38014085-43AA5681-49CE-4FC8-B7F4-C960F339E4FAQ38035301-CE91B9CE-16D7-40D8-A479-BA997550AF5CQ38073760-16DAFAAF-1758-4CEF-9693-7C4652F0B9C2Q38098383-29659D41-BCF8-42D0-B459-F9D668A7FA3AQ38178966-DAB9A889-8914-45F3-A263-759D8CFDE11AQ38203261-B8488897-B16F-4031-994F-22B14B6D43BBQ38262257-5B0ECDC9-C67D-410A-9FB7-3CA3490F2A23Q38383224-0361103E-E5E0-445A-B108-C35951EB0C7CQ38730881-9C2F99D3-1603-47B6-BBC8-D89D7E4A007BQ38849985-14DAA178-DC3C-4EDE-973C-DA74D40C3617Q39011291-27515AA2-B740-4951-A571-5DDEFBC08310Q39614809-3DC83742-B263-4BDE-95AB-0B1A8706D6C8Q39661000-CE38EB99-5478-4F2A-8AF5-BCFC5CC978AFQ40144217-1C52DE11-F1E5-4824-86D3-AD5D0E48A94FQ41639162-966F3ADE-82D7-40ED-8DF0-874B9E32E841Q41684097-47AAA7B7-18BD-4F2D-AA64-31E838A4C738Q46884989-BEC83D06-C4F6-4E31-B5CC-55BF050E8035Q47225796-2FC23F32-B97C-4D99-A218-680C76AB077EQ50204340-3375149A-5D12-4840-A844-866BAB48CA00Q52666760-B894796B-FD92-4301-9EF0-4E98EF5CAC0EQ58785685-20290013-8756-45F7-BD16-7E81C3B200B4
P2860
Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Selective induction of express ...... ptor by proteasome inhibitors.
@en
type
label
Selective induction of express ...... ptor by proteasome inhibitors.
@en
prefLabel
Selective induction of express ...... ptor by proteasome inhibitors.
@en
P2093
P1433
P1476
Selective induction of express ...... eptor by proteasome inhibitors
@en
P2093
Hugh T Reyburn
Pedro Roda-Navarro
Robin L Cassady-Cain
Susan E Chisholm
P304
P356
10.1158/0008-5472.CAN-07-2973
P407
P577
2008-03-01T00:00:00Z